Skip to main content
SpringerLink
Log in

Cosmetic Claim Substantiation in the United States: Legal Considerations

  • Chapter
Cosmetics

  • 757 Accesses

Abstract

Control of consumer product claims in the United States, including representations about cosmetic products, is governed by federal and state law, by private judicial actions against false and misleading advertising, and by programs administered by voluntary industry organizations. While with some exceptions, cosmetic labeling and advertising need not be approved prior to its use, a cosmetic marketer devising advertising and labeling statements for the United States must have a reasonable basis for, and be able to substantiate, claims. The potential penalties for making unsubstantiated claims include federal, state, and private sanctions. This chapter will identify the bases for claim substantiation requirements for cosmetic products in the United States.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 21 United States Code (USC) section 301 et seq.

    Google Scholar 

  2. 15 USC sections 1451-1461

    Google Scholar 

  3. 15 USC sections 42-58

    Google Scholar 

  4. 15 USC section 43(a)

    Google Scholar 

  5. Mail Fraud Act, 18 USC 1341-1342

    Google Scholar 

  6. 21 USC sections 331(a) and 361(a); 21CFR section 1.21

    Google Scholar 

  7. 21 USC section 321(m); US v. Kordel, 355 US 345 (1948)

    Google Scholar 

  8. 21 USC section 321(n); 21 Code of Federal Regulations (CFR) section 1.21

    Google Scholar 

  9. 15 USC sections 45,52,55(a)

    Google Scholar 

  10. Memorandum of Understanding between the FDA and FTC, 36 Federal Register (Fed Reg) 18,539 (1971)

    Google Scholar 

  11. 21 USC section 321(i)

    Google Scholar 

  12. 21 USC section 321(g)(1)

    Google Scholar 

  13. FDA, Nicotine in cigarettes and smokeless tobacco products is a drug and these products are nicotine delivery devices under the Federal Food, Drug, and Cosmetic Act, 60 Fed Reg 41454,41482 (August 11,1995)

    Google Scholar 

  14. FDA has issued proposed or final regulations for OTC drug products intended to treat or prevent conditions such as acne (21 CFR 333), chapped skin (21 CFR 347), topical itching and pain (21 CFR 348), tooth decay (21 CFR 355), warts and calluses (21 CFR 358, subpart B), dandruff, sebborhea and psoriasis (21 CFR 358, subpart H), and products such as skin lighteners, [47 Fed Reg 39108-117 (September 3,1982)],antiperspirants [47 FedReg 36492-505 (August 20,1982)],hair grower and hair loss prevention (21 CFR 310.527) and sunscreens [58 Fed Reg 28/94 May 12,1993]

    Google Scholar 

  15. United States v. An Article... Line Away, 283 F Supp 107 (D Del 1986), aff’d, 415 F 2d 369 (3rd Cir 1969)

    Google Scholar 

  16. United States v. An Article... Sudden Change, 288 F Supp 29 [EDNY 1968, rev’d, 409 F 2d 734 (2d Cir 1969)]

    Google Scholar 

  17. United States v. An Article...Magic Secret, 331 F Supp 912 (D Md 1971)

    Google Scholar 

  18. Line Away, 415 F 2d at 371

    Google Scholar 

  19. Letter from John M. Taylor, Associate Commissioner for Regulatory Affairs, to Stuart Friedel, Davis and Gilbert, re: Cosmetic Regulatory Letters, (November 19,1987)

    Google Scholar 

  20. 21 CFR section 701.1(b)

    Google Scholar 

  21. Revocation of Certain Regulations Affecting Food, 61 Fed Reg 27771 (June 3,1996) “Section 700.10 Shampoo preparations containing eggs as one of the ingredients is removed.”

    Google Scholar 

  22. 39 Fed Reg 7288 (February 25,1974)

    Google Scholar 

  23. Almay v. Joseph A Califano, 569 F 2d 674 (D C Cir)(1977), Revocation of Rule 43 Fed Reg 10559 (March 14,1978)

    Google Scholar 

  24. 21 CFR 310.50(a); see also 54 Fed Reg 40618, 40620 (October 20, 1989) (Proposed Rule on OTC Topical Hormone-Containing Drug Products); 58 Fed Reg 47611,47613 (September 9,1993) (Proposed rule on the use of hormones as ingredients in cosmetics); FDA Guide to Inspections of Cosmetic Product Manufacturers (1995), pp 7-8

    Google Scholar 

  25. Id., FDA Guide to Inspections of Cosmetic Product Manufacturers (1995), p 8

    Google Scholar 

  26. 15 USC section 5

    Google Scholar 

  27. 15 USC section 12

    Google Scholar 

  28. 15 USC section 15

    Google Scholar 

  29. Advertising Age, December 14,1981, p 6

    Google Scholar 

  30. FTC v. Colgate Palmolive Co, 380 US 374 (1965); Resort Rental Car Systems, Inc v. FTC, 518 F 2d 962 (9th Cir 1965)

    Google Scholar 

  31. Pfizer, Inc et al. , 81 FTC 23 (1972) 32. National Dynamics Corp, et al. , 82 FTC 488 (1973), aff’d and remanded on other grounds 492 F 2d 1333 (2d Cir 1973), cert. Denied 419 US 993 (1974), reissued 85 FTC 391 (1976)

    Google Scholar 

  32. Federal Register 49 (150) 30999-31001 (August 2,1984)

    Google Scholar 

  33. Federal Register 44 (157) 47378-47329 (August 13,1979)

    Google Scholar 

  34. Charles of the Ritz Dist Corp v. FTC, 143 F 2d 676 (2d Cir 1944)

    Google Scholar 

  35. US v. Braswell, Inc, et al. , No. C81-55 A (ND Ga September 14,1983); FTC v. Intra-Medic Formulations, Inc, et al. , (S D Fla February 28,1986)

    Google Scholar 

  36. Lustrasilk Corp of America, Inc, et al. , 87 FTC 145 (1976); The Perma-Strate Company, et al. , 87 FTC 155(1976); Soft and Sheen Company, Inc, et al. , 87 FTC 164 (1976); Johnson Products Company, Inc, et al. , 87 FTC 206 (1976); Revlon, Inc, et al. , 89 FTC 1 (1977)

    Google Scholar 

  37. CEB Products, Inc, et al. , 85 FTC 565,569,573 (1975)

    Google Scholar 

  38. Miriam Mascheck, Inc, et al, 85 FTC 536 (1975)

    Google Scholar 

  39. Carson Products Co, et al. , 86 FTC 1079 (1975)

    Google Scholar 

  40. Remarks of Christian S White, Acting Director, Bureau of Consumer Protection, Federal Trade Commission, Monday, September 13,1993, Hyatt Carlton Tower, Infomercial Teleshopping ’93

    Google Scholar 

  41. Johnson and Johnson-Merck Consumer Pharmaceuticals Co v. Rhone Poulenc Rorer Pharmaceuticals, Inc, 19 F 3d 125 (3d Cir 1994)

    Google Scholar 

  42. McNeil-PCC, Inc v. Bristol-Myers Squibb Co, 938 F 2d 1544 (2d Cir 1991)

    Google Scholar 

  43. Serbin v. Ziebart International Corp, 11 F 3d 1163 (3d Cir 1993); Barros v. Sylvania, 34 USPQ 2d 1859 (9th Cir 1995)

    Google Scholar 

  44. Stenfield v. Osborne Industries, Inc, 52 F 3d 867 (10th Cir 1995); Ortho Pharmaceutical Corp v. Cosprophar, Inc, 32 F 3d 690 (2d Cir 1994)

    Google Scholar 

  45. California Business and Professional Code § 17508 47. Roberts D (1995) Substantiating cosmetic advertising claims. Society of Cosmetic Chemists Program, December 6,1995

    Google Scholar 

  46. Council of Better Business Bureaus, Inc, National Advertising Division, Childrens Advertising Review Unit and National Advertising Review board Procedures, November 1,1993

    Google Scholar 

Download references

Authors
  1. G. N. McEwen Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. G. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum der Friedrich Schiller-Universität Jena Klinik für Hautkrankheiten, Erfurter Straße 35, D-07740, Jena, Germany

    P. Elsner

  2. Department of Dermatology, University of California San Francisco School of Medicine, Surge 110, Box 0989, 94143-0989, San Francisco, CA, USA

    Howard I. Maibach M.D. (Professor) (Professor)

  3. Rheinisch-Westfälische Technische Hochschule Aachen Hautklinik, Pauwelsstraße 30, D-52074, Aachen, Germany

    Hans F. Merk

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McEwen, G.N., Murphy, E.G. (1999). Cosmetic Claim Substantiation in the United States: Legal Considerations. In: Elsner, P., Maibach, H.I., Merk, H.F. (eds) Cosmetics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59869-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59869-2_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64160-2

  • Online ISBN: 978-3-642-59869-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation